Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2021
Updated 2021 – 22 cost recovery implementation statement
30 November 2021 - The 2021-22 Pharmaceutical Benefits Scheme and National Immunisation Plan Cost Recovery Implementation Statement has been updated ...
Posted by Michael Wonder on 28 Nov 2021
New treatment for Australians with leukaemia
28 November 2021 - From 1 December 2021, Australians with acute myeloid leukaemia will have access to a new treatment option ...
Posted by Michael Wonder on 27 Nov 2021
Here we go again - version 2.0
26 November 2021 - The agenda for the March 2022 PBAC agenda has been revised within 48 hours of publication. ...
Posted by Michael Wonder on 26 Nov 2021
Additional insights from the agenda for the March 2022 PBAC meeting
26 November 2021 - More insights from the MAESTrO Team. ...
Posted by Michael Wonder on 25 Nov 2021
Insights from the agenda (version 1.0) for the March 2022 PBAC meeting
26 November 2021 - Some insights from the MAESTrO Team. ...
Posted by Michael Wonder on 25 Nov 2021
Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...
Posted by Michael Wonder on 25 Nov 2021
Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies
25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...
Posted by Michael Wonder on 24 Nov 2021
Agenda for the March 2022 PBAC meeting
24 November 2021 - The agenda for the March 2022 PBAC meeting is now available. ...
Posted by Michael Wonder on 24 Nov 2021
Semaglutide (Wegovy) stakeholder meeting outcome statement
24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...
Posted by Michael Wonder on 22 Nov 2021
New PBS listing helps Australians with rare genetic condition
21 November 2021 - From 1 December 2021, Australians with a rare and potentially deadly condition, hereditary angioedema, will be able ...
Posted by Michael Wonder on 21 Nov 2021
Rare condition medication going on PBS
21 November 2021 - From next month a medication for a rare and potentially deadly genetic condition with be available ...
Posted by Michael Wonder on 15 Nov 2021
Supporting Australians with rare stomach and bowel cancer
15 November 2021 - The Morrison Government will list Qinlock (ripretinib) on the PBS for the treatment of advanced gastro-intestinal stromal ...
Posted by Michael Wonder on 14 Nov 2021
Rare cancer drug to be subsidised
14 November 2021 - A drug to treat a rare stomach and bowel cancer will be subsidised after being listed ...
Posted by Michael Wonder on 13 Nov 2021
Public Summary Documents (first time rejections and deferrals) – July 2021 PBAC meeting
12 November 2021 - The Public Summary Documents (first time rejections and deferrals) from the July 2021 PBAC meeting are now ...
Posted by Michael Wonder on 12 Nov 2021
Progress update: post-market review of medicines for smoking cessation
12 November 2021 - In June 2021, the Drug Utilisation Sub-Committee and the Economics Sub-Committee of the PBAC considered the report ...